SCHEMBL212716

SCHEMBL212716

CC(C)c1cc(C(=O)O)c(O)c(C(C)C)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 2/20 0.60
FABP4 P15090 2/20 0.60
GABRA1 P14867 5/20 0.57
GABRB2 P47870 2/20 0.57
ALDH1A1 P00352 3/20 0.47
HPGD P15428 3/20 0.47
KDM4E B2RXH2 2/20 0.47
GAA P10253 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
FABP5 Q01469 1/20 0.44
BCL2 P10415 2/20 0.44
MCL1 Q07820 2/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
GABRB1 P18505 4/20 0.43
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29593831 1.00 FABP3 (0.60) FABP3FABP4GABRA1GABRB2ALDH1A1
Benzene SCHEMBL9253514 0.98 FABP3 (0.58) FABP3FABP4GABRA1GABRB2ALDH1A1
Water SCHEMBL5706121 0.98 FABP3 (0.58) FABP3FABP4GABRA1GABRB2ALDH1A1
SCHEMBL28203848 0.98 FABP3 (0.58) FABP3FABP4GABRA1GABRB2ALDH1A1
SCHEMBL10618114 0.98 FABP3 (0.58) FABP3FABP4GABRA1GABRB2ALDH1A1
SCHEMBL11797932 0.98 FABP3 (0.58) FABP3FABP4GABRA1GABRB2ALDH1A1
SCHEMBL11783529 0.98 FABP3 (0.58) FABP3FABP4GABRA1GABRB2ALDH1A1
SCHEMBL11794494 0.98 FABP3 (0.58) FABP3FABP4GABRA1GABRB2ALDH1A1
SCHEMBL6910525 0.98 FABP3 (0.58) FABP3FABP4GABRA1GABRB2ALDH1A1
SCHEMBL11783537 0.98 FABP3 (0.58) FABP3FABP4GABRA1GABRB2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144729-A1 A CLEANSING COMPOSITION L'OREAL (FR) 2026-05-28 US claimed
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 CN claimed
CN-117925335-A Semiconductor titanium nitride cleaning solution, and preparation method and application thereof 浙江奥首材料科技有限公司 2024-04-26 CN claimed
CN-116023782-B Antibacterial flame-retardant nylon composite material and preparation method thereof 宁波锦地工程塑料有限公司 2024-04-09 CN claimed
CN-117164875-A Preparation method of tubular metal copper phthalocyanine polymer and cyclic carbonate 浙江理工大学 2023-12-05 CN claimed
CN-116814311-A Chemical for coke inhibition in fuel and oil systems, application and delivery methods 通用电气公司 2023-09-29 CN claimed
US-20230304445-A1 CHEMISTRIES, APPLICATION, AND DELIVERY METHODS FOR COKE INHIBITION IN FUEL AND OIL SYSTEMS GENERAL ELECTRIC COMPANY 2023-09-28 US claimed
CN-114959299-B Method for recovering cobalt from copper raffinate of cobalt-containing copper oxide ore 重庆康普化学工业股份有限公司 2023-08-22 CN claimed
CN-115322589-B Pigment not easy to fade and preparation method thereof 杭州萧山环保化工有限公司 2023-07-25 CN claimed
CN-116023782-A Antibacterial flame-retardant nylon composite material and preparation method thereof 宁波锦地工程塑料有限公司 2023-04-28 CN claimed
US-4470980-A Method of increasing oral absorption of β-lactam antibiotics INTERX RESEARCH CORP. (US) 1984-09-11 US claimed
US-4464363-A HYDROXY ARYL- OR HYDROXY ARALKYL ACIDS OR SALTS MERCK & CO., INC. (US) 1984-08-07 US claimed
US-4406896-A ANTIBIOTICS, ACIDS, HYDROXY MERCK & CO., INC. (US) 1983-09-27 US claimed
US-4374671-A CONTAINING ZINC OXIDE, A SALICYCLIC ACID AND A METAL SISLICATE FUJI PHOTO FILM CO.LTD. (JP) 1983-02-22 US claimed
EP-0036534-A1 An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-30 EP claimed
EP-0036145-A1 An orally administered drug form comprising a polar bioactive agent and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-23 EP claimed
EP-0035770-A2 An orally administered drug form comprising a glycosidic antibiotic and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-16 EP claimed
EP-0031561-A2 A rectally administered suppository comprising a drug and an adjuvant MERCK & CO. INC. (US) 1981-07-08 EP claimed
US-4221785-A COORDINATION COMPOUND OF A COPPER SALT AND A SALICYLIC ACID OR ITS DERIVATIVE J.R.J. SORENSON CORP. 1980-09-09 US claimed
US-4121013-A 3,5-SUBSTITUTED SALICYLIC ACID, ZINC COMPOUND, AMMONIUM HYDROXIDE, COATINGS, SENSITIZED FOR COLOR DEVELOPMENT NCR CORPORATION (US) 1978-10-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260144729-A1 A CLEANSING COMPOSITION SMURF1, CUTA, S100B FABP3 1094/4885FABP4 104/4885GABRA1 828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.